Form 4 for ELV Elevance Health
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-06 · accession 0001156039-24-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-08 | 2024-03-06 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale | $504.58 | -916 | 1,764 | -34% | -$462.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-06 | S | D | 916 | $504.58 | 1,764 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $504.56 to $504.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |